Is there a conflict of interest?
The U.S. Senate Committee on Agriculture, Nutrition, and Forestry held a biotechnology hearing for the first time in 10 years last week to discuss the future of food technology as the industry responds to increased demand, production challenges, and consumers’ calls for a safe and transparent food supply. But the meeting came up short on transparency and carried on more like a Monsanto share-holders meeting than an unbiased inquiry into the pros and cons of biotechnology where it concerns the food supply.
Senator after senator praised biotechnology and genetically modified foods, claiming they had ‘come a long way’ in ten years. Pamela Bailey, president and CEO of the Grocery Manufacturers Association said:
“The Senate Agriculture hearing reaffirmed the broad consensus among scientists and regulators that GMOs are safe and highlighted the real world negative impacts a patchwork of state labeling mandates will have on farmers, businesses and consumers. Action by Congress is urgently needed this year to pass a national, uniform labeling standard.”
The senate hearing was scheduled shortly after the US House of Representatives passed the “Safe and Accurate Food Labeling Act of 2015,” otherwise known as the DARK Act (Deny Americans the Right to Know) by a vote of 275-150.